Atea Pharmaceuticals, Inc. (AVIR) market cap

Market cap today
$318.00M

Atea Pharmaceuticals, Inc. (AVIR) has a market cap of $318.00M. At the end of fiscal 2025 (December 31, 2025) its market cap was $290.94M. That is 3.1% higher than the $282.29M of fiscal 2024. Today's figure is 9.3% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 06:43 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$318.00M
Market cap, fiscal 2025
$290.94M
Change on fiscal 2024
+3.1%
Growth, 5 years
−20.3% a year
Highest on record
$902.13Mfiscal 2020
Lowest on record
$254.34Mfiscal 2023
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Atea Pharmaceuticals, Inc. market cap, in more detail

Over the five fiscal years to 2025 the market cap shrank at a compound 20.3% a year. Across the 6 fiscal year-ends on record (2020–2025), the highest was $902.13M in fiscal 2020 and the lowest $254.34M in fiscal 2023.

History · 6 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Atea Pharmaceuticals, Inc. market cap, year by year

Atea Pharmaceuticals, Inc. (AVIR) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$318.00M—$3.96—
2025$290.94M 3.1% up$3.5781.50M
2024$282.29M 11.0% up$3.3584.26M
2023$254.34M 36.5% down$3.0583.39M
2022$400.41M 49.2% down$4.8183.25M
2021$788.95M 12.5% down$8.9488.25M
2020$902.13M—$41.7821.59M
2019———10.09M

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

More on AVIR

Atea Pharmaceuticals, Inc., figure by figure

Atea Pharmaceuticals, Inc. (AVIR) overview: price, valuation and scorecard

Atea Pharmaceuticals, Inc. market cap: questions and answers

What is Atea Pharmaceuticals, Inc.'s market cap?

Atea Pharmaceuticals, Inc. (AVIR) has a market cap of $318.00M. At the end of fiscal 2025 (December 31, 2025) its market cap was $290.94M. That is 3.1% higher than the $282.29M of fiscal 2024.

What is the growth rate of Atea Pharmaceuticals, Inc.'s market cap?

Over the five fiscal years to 2025 the market cap shrank at a compound 20.3% a year.

What are the highest and lowest market cap figures on record for Atea Pharmaceuticals, Inc.?

Across the 6 fiscal year-ends on record (2020–2025), the highest was $902.13M in fiscal 2020 and the lowest $254.34M in fiscal 2023.

How is Atea Pharmaceuticals, Inc.'s market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Atea Pharmaceuticals, Inc. (AVIR) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/AVIR/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.